GERM 发表于 2025-3-21 19:35:21

        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/if/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)影响因子@(免疫学)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=1871A5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)总引论文<br>        http://impactfactor.cn/2024/at/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)总引论文@(免疫学)学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=1871A5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/tc/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)总引频次@(免疫学)学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=1871A5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)即时影响因子<br>        http://impactfactor.cn/2024/ii/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)即时影响因子@(免疫学)学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=1871A5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)五年累积影响因子<br>        http://impactfactor.cn/2024/5y/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)五年累积影响因子@(免疫学)学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=1871A5303<br><br>       

Digest 发表于 2025-3-21 23:23:03

Submitted on: 03 July 2015.
Revised on: 20 October 2015.
Accepted on: 15 December 2015.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

scrutiny 发表于 2025-3-22 01:52:01

Submitted on: 19 May 2008.
Revised on: 04 August 2008.
Accepted on: 25 September 2008.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

失眠症 发表于 2025-3-22 07:30:46

Submitted on: 07 July 2012.
Revised on: 27 July 2012.
Accepted on: 02 September 2012.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

平项山 发表于 2025-3-22 10:54:28

Submitted on: 10 September 2020.
Revised on: 04 October 2020.
Accepted on: 14 October 2020.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Inscrutable 发表于 2025-3-22 14:27:29

Submitted on: 10 February 2023.
Revised on: 16 May 2023.
Accepted on: 12 June 2023.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Dysarthria 发表于 2025-3-22 19:09:43

http://reply.papertrans.cn/1/84/8344/8344-7.png

Hemiplegia 发表于 2025-3-22 21:18:56

http://reply.papertrans.cn/1/84/8344/8344-8.png

catagen 发表于 2025-3-23 05:23:41

Submitted on: 17 May 2002.
Revised on: 01 August 2002.
Accepted on: 13 August 2002.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

1分开 发表于 2025-3-23 06:41:34

Submitted on: 24 February 2004.
Revised on: 18 May 2004.
Accepted on: 05 July 2004.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets
页: [1] 2 3 4
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (IMMUN